Order byBest matchMost fresh

FDA, Covid

Digest more
Top News
Overview
Impacts
FDA set to unveil new Covid vax guidelines today
While details of the guidance remain closely held, some clues are likely found in the FDA’s late Friday letter approving Novavax’s Covid vaccine. Who can get it: The license covers a limited population — adults 65 and older and people ages 12 to 64 with at least one underlying condition putting them at high risk for severe disease — compared with the two messenger RNA shots available for Covid recommended for all people 12 and older.

Continue reading

Medscape · 2h
FDA Will Prioritize COVID Vaccine Approval for 65 and Older and High Risk
Science News · 1h
FDA significantly limits access to COVID-19 vaccines
US FDA advisers to consider if new COVID shots should target LP.8.1 subvariant
The U.S. Senate plans to vote this week to bar California's landmark plan to end the sale of gasoline-only vehicles by 2035 that has been adopted by 11 other states, Majority Leader John Thune said on...

Continue reading

Annual COVID-19 Shots For Healthy Younger Adults, Children Will No Longer Be Routinely Approved
US regulators say annual COVID-19 shots for healthy younger adults and children will no longer be routinely approved
FDA sets new COVID booster guidelines for healthy adults under 65
Vaccine makers have argued that because COVID vaccines have been changed annually to match the circulating strain of the virus, new placebo-controlled trials could delay availability of the shots unt...

Continue reading

F.D.A. Poised to Restrict Access to Covid Vaccines
FDA to limit future Covid-19 shots to older people and those at risk of serious infection
Devdiscourse5d
Global Health Headlines: Impactful Investments and Policy Shifts
Sanofi expands its U.S. manufacturing with a $20 billion investment. The FDA approves Merck's cancer drug for rare adrenal tumors. European Court challenges transparency in EU's COVID vaccine negotiations.
The Washington Post5d
FDA to issue new vaccine approval guidance amid questions over coronavirus shots
Send in your questions here. End of carousel The FDA was on track to grant full approval for the vaccine April 1, according to two people familiar with the matter who spoke on the condition of ...
US FDA expands use of Merck's cancer drug for adrenal gland tumors
The drug, Welireg, became the first FDA-approved oral treatment for the two tumors — pheochromocytoma and paraganglioma. The regulator's approval was based on a study in which Welireg showed an objective response rate of 20.
kpvi3h
US limits Covid boosters to over-65s or those at high risk
The United States will limit Covid-19 boosters to people over 65 or those at risk of serious illness, while requiring vaccine makers to run fresh clinical trials before offering shots
You asked: Are vaccines approved without safety studies?
No, this is not true. Vaccines undergo rigorous safety testing and are continuously monitored for adverse events.
Live Science on MSN1d
2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayed
Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect the shot's approval may be delayed.
Feedback